Get the Stockscreener App
3.28
2.82%
0.09
Sensus Healthcare Inc stock is traded at $3.28, with a volume of 22,501.
It is up +2.82% in the last 24 hours and down -16.75% over the past month.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
See More
Previous Close:
$3.19
Open:
$3.19
24h Volume:
22,501
Relative Volume:
0.35
Market Cap:
$52.68M
Revenue:
$22.53M
Net Income/Loss:
$-7.77M
P/E Ratio:
-6.9082
EPS:
-0.4748
Net Cash Flow:
$-740.00K
1W Performance:
-2.09%
1M Performance:
-16.75%
6M Performance:
-20.19%
1Y Performance:
-30.06%
1-Day Range:
$3.18
$3.29
1-Week Range:
$3.10
$3.5541
52-Week Range:
$2.82
$5.92
Sensus Healthcare Inc Stock (SRTS) Company Profile
Name
Sensus Healthcare Inc
Sector
Industry
Phone
561-922-5808
Address
851 BROKEN SOUND PARKWAY NW, BOCA RATON, FL
Compare SRTS vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SRTS
Sensus Healthcare Inc
|
3.20 | 52.51M | 22.53M | -7.77M | -740.00K | -0.4748 |
ABT
Abbott Laboratories
|
86.33 | 152.25B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
310.77 | 121.33B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
77.61 | 100.91B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.77 | 85.88B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.85 | 49.39B | 6.30B | 1.07B | 1.09B | 1.8406 |
Sensus Healthcare Inc Stock (SRTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-26 | Initiated | Alliance Global Partners | Buy |
| Jan-31-25 | Initiated | Lake Street | Buy |
| Nov-15-24 | Reiterated | Maxim Group | Buy |
| Feb-26-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Dec-16-20 | Downgrade | Northland Capital | Outperform → Market Perform |
| Aug-10-20 | Upgrade | Alliance Global Partners | Neutral → Buy |
| Feb-14-20 | Upgrade | Alliance Global Partners | Neutral → Buy |
| Nov-07-19 | Downgrade | B. Riley FBR | Buy → Neutral |
| Jan-29-19 | Downgrade | Northland Capital | Market Perform → Under Perform |
| Sep-26-18 | Initiated | B. Riley FBR | Buy |
| Nov-03-17 | Reiterated | Maxim Group | Buy |
| Jun-06-17 | Initiated | Maxim Group | Buy |
| Aug-08-16 | Initiated | Northland Capital | Outperform |
View All
Sensus Healthcare Inc Stock (SRTS) Latest News
Sensus Healthcare (SRTS) Posts Weak Q1 2026 — Misses on Both Top and Bottom LinesCrowd Stock Picks - Newser
Sensus Healthcare (SRTS) Q1 2026 Earnings: Miss Sparks ConcernOne-Time Loss Impact - Newser
SRTS to Host Virtual Meeting on May 21 - GuruFocus
Sensus Healthcare Balances Weak Quarter With Growth Catalysts - TipRanks
How The Sensus Healthcare (SRTS) Story Is Shifting With New Targets And 2026 Reimbursement Changes - Yahoo Finance
Number of shareholders of Sensus Healthcare, Inc. – TRADEGATE:5TX - TradingView
Sensus Healthcare Q1 earnings call highlights - MSN
Sensus outlines full year profitability goal for 2026 as new CPT codes take effect - MSN
TradingKey - TradingKey
Skin cancer cases rising in the U.S., report says (Video) - Social News XYZ
Sensus Healthcare 1Q 2026: Revenue $3.39M, EPS $(0.16) — 10-Q Summary - TradingView
[10-Q] Sensus Healthcare, Inc. Quarterly Earnings Report - Stock Titan
Skin cancer cases rising in the U.S., report says - CBS News
SRTS Director Eric Sachetta Buys 1,500 Shares on May 13, 2026 - Meyka
Maxim Group Maintains Sensus Healthcare(SRTS.US) With Buy Rating, Maintains Target Price $6 - Moomoo
Sensus Healthcare director Eric Sachetta buys $5,002 in stock By Investing.com - Investing.com Nigeria
Sensus Healthcare director Eric Sachetta buys $5,002 in stock - Investing.com
Sensus Healthcare (SRTS) director Eric Sachetta adds 1,500 shares in open-market buy - Stock Titan
Sensus Healthcare, Inc. (SRTS) Falls More Steeply Than Broader Market: What Investors Need to Know - MSN
Sensus Healthcare Reports Transition to New Radiotherapy Reimbursement Model - HarianBasis.co
Q1 2026 Sensus Healthcare Inc Earnings Call Transcript - GuruFocus
Sensus Healthcare Q1 Earnings Call Highlights - Barchart.com
Sensus Healthcare Charts Recovery Path Amid Revenue Drop - TipRanks
SRTS Sensus Healthcare stock craters 26.6% after 34% revenue decline raises investor concerns.Expert Entry Points - newser.com
Lake Street Maintains Sensus Healthcare(SRTS.US) With Buy Rating, Cuts Target Price to $4.5 - Moomoo
Sensus Healthcare Announces Amicable Resolution Of Commercial Dispute With SkinCure Oncology - TradingView
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Sensus Healthcare Announces Amicable Resolution of Commercial Dispute with SkinCure Oncology - Business Wire
A. G. P. Maintains Sensus Healthcare(SRTS.US) With Buy Rating, Cuts Target Price to $6.5 - Moomoo
Sensus Healthcare, Inc. (NASDAQ:SRTS) Q1 2026 Earnings Call Transcript - Insider Monkey
SRTS Reports Q1 Revenue and Highlights New CPT Codes Impact - GuruFocus
How Sensus Healthcare (SRTS) manages its cash position | Q1 2026: Earnings UnderperformRegulatory Risk - newser.com
Earnings call transcript: Sensus Healthcare misses Q1 2026 forecasts By Investing.com - Investing.com Australia
Earnings call transcript: Sensus Healthcare misses Q1 2026 forecasts - Investing.com
Sensus Healthcare Inc (NASDAQ:SRTS) Misses Q1 Estimates as Revenue Drops, But New CPT Codes Provide a Tailwind - ChartMill
Sensus (SRTS) Q1 2026 Earnings Transcript - AOL.com
Sensus Healthcare Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Sensus Healthcare, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Revenue falls as Sensus Healthcare (NASDAQ: SRTS) ends Q1 with $18.3M cash - Stock Titan
Sensus Healthcare Reports First Quarter 2026 Financial Results and Business Highlights - Business Wire
Pleasing Signs As A Number Of Insiders Buy Sensus Healthcare Stock - Yahoo Finance
Earnings Preview: SRTS to Report Financial Results Post-market on May 07 - Moomoo
Sensus Healthcare, Inc. (NASDAQ:SRTS) Short Interest Up 14.7% in April - MarketBeat
Sensus Healthcare (SRTS) Projected to Post Earnings on Thursday - MarketBeat
Sensus Healthcare (NASDAQ:SRTS) Shares Pass Below 50-Day Moving AverageHere's Why - MarketBeat
Sensus Healthcare Inc Stock (SRTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Sensus Healthcare Inc Stock (SRTS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Sachetta Eric | Director |
Feb 24 '26 |
Buy |
3.81 |
2,000 |
7,620 |
142,113 |
| Sachetta Eric | Director |
Nov 21 '25 |
Buy |
3.93 |
7,000 |
27,510 |
140,113 |
| Sachetta Eric | Director |
Nov 13 '25 |
Buy |
4.50 |
2,500 |
11,250 |
133,113 |
| Sardano Joseph C | CHIEF EXECUTIVE OFFICER |
Nov 18 '25 |
Buy |
4.03 |
25,000 |
100,750 |
1,200,293 |
| Sardano Michael | PRESIDENT AND GENERAL COUNSEL |
Nov 18 '25 |
Buy |
3.80 |
1,000 |
3,800 |
118,839 |
| Sardano Michael | PRESIDENT AND GENERAL COUNSEL |
Nov 11 '25 |
Buy |
4.26 |
1,000 |
4,260 |
117,839 |
| Sardano Michael | PRESIDENT AND GENERAL COUNSEL |
Aug 13 '25 |
Buy |
3.37 |
1,000 |
3,370 |
116,839 |
0.32%
0.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):